20/20 GeneSystems News

JANUARY 17, 2010

Smiths Detection to Distribute BioCheck® Worldwide

September 29, 2008

20/20 Awarded $650K Phase II SBIR Grant to Develop Test to "Personalize" Breast Cancer Therapies

January 17 , 2008

20/20 Licenses Lung Cancer Blood Test to Ortho-Clinical Diagnostics

dECEMBER 18, 2007

BIRD Foundation Awards 20/20 GeneSystems and ImmunArray Shared $1 Million Award

NOVEMBER 5 , 2007

20/20 receives $150,000 in joint funding from Johnson & Johnson and TEDCO.

October 5 , 2007

BioCheck® Kit for Screening Suspicious Powders Receives SAFETY Act Designation from DHS

september 27 , 2007

20/20 wins $2M ATP award to further develop LES Technology

July 3 , 2007

20/20 Announces Significant Development of Innovative Layered Peptide Array Technology

February, 2007

20/20 Closes $1.75 Investment Round. Company Leverages New Maryland Investor Tax Credit.

December 13, 2006

20/20 Moves into New Headquarters

JULY 18, 2006

20/20 Investors Seek Refund through New Maryland Biotech Investment Incentive Act

JULY 14, 2006

20/20 announces a report published in the Journal of Thoracic Oncology showing that its multi-biomarker blood test appears able to detect non-small cell lung cancer (NSCLC) significantly earlier and with better accuracy than existing tests. 

JULY 13, 2006

20/20 Receives an STTR Award To Further Develop a Diagnostic Test for Early Stage Lung Cancer

Dec 29, 2005
Second Patent Issued to 20/20 for its BioCheck technology

Dec. 13, 2005
20/20 GeneSystems Acquires Rights to Lung Cancer Screening Test from U. Kentucky

May 13, 2005
New Data Using 20/20 Membranes Described at Scientific Meeting

Apr 2005
20/20 Technology featured in article and cover of journal 'Dermatology'

Go to the News Archive...